ES2167536T3 - Vacuna dirigida contra el agente de la anemia infecciosa en pollos de engorde. - Google Patents

Vacuna dirigida contra el agente de la anemia infecciosa en pollos de engorde.

Info

Publication number
ES2167536T3
ES2167536T3 ES96900947T ES96900947T ES2167536T3 ES 2167536 T3 ES2167536 T3 ES 2167536T3 ES 96900947 T ES96900947 T ES 96900947T ES 96900947 T ES96900947 T ES 96900947T ES 2167536 T3 ES2167536 T3 ES 2167536T3
Authority
ES
Spain
Prior art keywords
chickens
huge
agent
directed against
infectious anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96900947T
Other languages
English (en)
Inventor
Carla Christina Schrier
Dijk Pieter Matthijs Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2167536T3 publication Critical patent/ES2167536T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION DESCRIBE POR PRIMERA VEZ UN PROBLEMA SANITARIO QUE SE PRESENTA EN POLLOS, QUE EMERGE EN APROXIMADAMENTE 3-5 SEMANAS, Y DA COMO RESULTADO IMPORTANTES PERDIDAS EN LA PRODUCCION, Y DEMUESTRA QUE ESTAS PERDIDAS EN LA PRODUCCION PUEDEN EVITARSE MEDIANTE UNA VACUNA DEL CAA (AGENTE DE LA ANEMIA EN POLLOS) VIVA ATENUADA, PARA LA ADMINISTRACION A LAS MUCOSAS.
ES96900947T 1995-01-06 1996-01-04 Vacuna dirigida contra el agente de la anemia infecciosa en pollos de engorde. Expired - Lifetime ES2167536T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200018 1995-01-06

Publications (1)

Publication Number Publication Date
ES2167536T3 true ES2167536T3 (es) 2002-05-16

Family

ID=8219942

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96900947T Expired - Lifetime ES2167536T3 (es) 1995-01-06 1996-01-04 Vacuna dirigida contra el agente de la anemia infecciosa en pollos de engorde.

Country Status (12)

Country Link
US (1) US6270770B1 (es)
EP (1) EP0802796B1 (es)
JP (1) JP4050312B2 (es)
AT (1) ATE206310T1 (es)
AU (1) AU4486096A (es)
BR (1) BR9606725A (es)
DE (1) DE69615656T2 (es)
DK (1) DK0802796T3 (es)
ES (1) ES2167536T3 (es)
MX (1) MX9705068A (es)
PT (1) PT802796E (es)
WO (1) WO1996020727A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
RS58729B1 (sr) 2010-10-13 2019-06-28 Celanese Int Corp Postupak za obnavljanje halogenih promotera i uklanjanje jedinjenja koja redukuju permanganat
CN106248932A (zh) * 2016-08-18 2016-12-21 山东新四维农业科技有限公司 一种用于优质中型青年蛋鸡的鉴别方法
CN115058522B (zh) * 2022-07-21 2023-06-13 江苏省家禽科学研究所 一种鉴定含有白洛克血缘的肉鸡品种的分子标记及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
ZA927014B (en) 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.
US5686077A (en) * 1991-09-20 1997-11-11 Akzo Nobel N.V. Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)

Also Published As

Publication number Publication date
DE69615656T2 (de) 2002-08-01
PT802796E (pt) 2002-02-28
BR9606725A (pt) 1998-01-13
US6270770B1 (en) 2001-08-07
EP0802796B1 (en) 2001-10-04
MX9705068A (es) 1997-10-31
JPH10511945A (ja) 1998-11-17
DE69615656D1 (de) 2001-11-08
WO1996020727A1 (en) 1996-07-11
AU4486096A (en) 1996-07-24
ATE206310T1 (de) 2001-10-15
EP0802796A1 (en) 1997-10-29
DK0802796T3 (da) 2002-01-21
JP4050312B2 (ja) 2008-02-20

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
IT7830192A0 (it) 1,4-di-idro-piridine nitro-sostituite, procedimenti per la loro preparazione e loro impiego come prodotti medicinali.
ES2126919T3 (es) Taxanos semisinteticos con actividad antitumoral.
EP0979080A4 (en) METHOD FOR MODULATING THE IMMUNE REACTION IN AN INFECTIVE MAMMALIAN BY THE TRANSMUCOSAL ENTERING A MODULATING AGENT
ES2167536T3 (es) Vacuna dirigida contra el agente de la anemia infecciosa en pollos de engorde.
HUP0203295A2 (hu) Emphysema kezelése RAR-szelektív retinoid agonistákat tartalmazó gyógyszerkészítmények felhasználásával
MX9205336A (es) Vacuna contra el agente de la anemia del pollo.
MA27059A1 (fr) Azithromycine en dose unique
HUP9701586A2 (hu) Javított inaktivált vakcinák
ATE81004T1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
HUT54051A (en) Process for producing pharmaceutical compositions for diminishing intraokular pressure
MA22812A1 (fr) Produits antimottants, compositions contenant des produits et traitements mettant ces produits en oeuvre.
FR2725990B1 (fr) Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
NL300121I1 (nl) Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
MXPA05012219A (es) Vacuna aviar combinada contra e. coli y salmonella.
PT603386E (pt) Imunizacao parenterica contra rotavirus
DK0519983T3 (da) Anvendelse af ketorolac til behandling af periodontal sygdom
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ES2192608T3 (es) Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.
HU0100908D0 (en) Chicken anaemia viruses of low pathogenicity
BR9206760A (pt) Amálgama para obturações e método de preparação dos componentes da amálgama
RU98121717A (ru) Способ лечения аллергических заболеваний
ECSP951438A (es) Formas de dosificacion de liberacion controlada de azitromicina